Clinical Outcomes After Bowel Resection in Patients Receiving Alvimopan Versus Patients Not Receiving Alvimopan in the Premier Perspective Database
Clinical trial NCT01150760 · COMPLETED
Trial details
- NCT number
- NCT01150760
- Sponsor
- Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2010-04-01
- Primary completion
- 2010-08-01
- Enrollment
- 7050
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.